320 related articles for article (PubMed ID: 25776897)
1. Intravenous immunoglobulin improves sepsis-induced coagulopathy: A retrospective, single-center observational study.
Ishikura H; Nakamura Y; Kawano Y; Tanaka J; Mizunuma M; Ohta D; Nishida T; Murai A
J Crit Care; 2015 Jun; 30(3):579-83. PubMed ID: 25776897
[TBL] [Abstract][Full Text] [Related]
2. Combination of thrombin-antithrombin complex, plasminogen activator inhibitor-1, and protein C activity for early identification of severe coagulopathy in initial phase of sepsis: a prospective observational study.
Koyama K; Madoiwa S; Nunomiya S; Koinuma T; Wada M; Sakata A; Ohmori T; Mimuro J; Sakata Y
Crit Care; 2014 Jan; 18(1):R13. PubMed ID: 24410881
[TBL] [Abstract][Full Text] [Related]
3. COMPREHENSIVE THERAPEUTIC EFFICACY ANALYSIS OF INTRAVENOUS IMMUNOGLOBULIN IN TREATING SEPSIS-INDUCED COAGULOPATHY: A SINGLE-CENTER, RETROSPECTIVE OBSERVATIONAL STUDY.
Fang J; Huang P; Cui W; Lin Y; Rong D; Li X
Shock; 2024 Jul; 62(1):4-12. PubMed ID: 38321608
[TBL] [Abstract][Full Text] [Related]
4. Intravenous Immunoglobulin G Modulates the Expression of Sepsis-Induced Coagulopathy Factors and Increases Serum IgM Levels: A Prospective, Single-Center Intervention Study.
Ando Y; Inoue S; Kawashima T; Okashiro M; Kotani J; Nishiyama T
Kobe J Med Sci; 2020 Jun; 66(1):E32-E39. PubMed ID: 32814755
[TBL] [Abstract][Full Text] [Related]
5. Biomarker response to drotrecogin alfa (activated) in children with severe sepsis: results from the RESOLVE clinical trial*.
Dalton HJ; Carcillo JA; Woodward DB; Short MA; Williams MD
Pediatr Crit Care Med; 2012 Nov; 13(6):639-45. PubMed ID: 22791090
[TBL] [Abstract][Full Text] [Related]
6. Activation of the extrinsic coagulation pathway in patients with severe sepsis and septic shock.
Gando S; Nanzaki S; Sasaki S; Aoi K; Kemmotsu O
Crit Care Med; 1998 Dec; 26(12):2005-9. PubMed ID: 9875912
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms and management of the coagulopathy of trauma and sepsis: trauma-induced coagulopathy, sepsis-induced coagulopathy, and disseminated intravascular coagulation.
Iba T; Helms J; Neal MD; Levy JH
J Thromb Haemost; 2023 Dec; 21(12):3360-3370. PubMed ID: 37722532
[TBL] [Abstract][Full Text] [Related]
8. Predicting the severity of systemic inflammatory response syndrome (SIRS)-associated coagulopathy with hemostatic molecular markers and vascular endothelial injury markers.
Iba T; Gando S; Murata A; Kushimoto S; Saitoh D; Eguchi Y; Ohtomo Y; Okamoto K; Koseki K; Mayumi T; Ikeda T; Ishhikura H; Ueyama M; Ogura Y; Endo S; Shimazaki S;
J Trauma; 2007 Nov; 63(5):1093-8. PubMed ID: 17993956
[TBL] [Abstract][Full Text] [Related]
9. Changes of the hemostatic network in critically ill patients--is there a difference between sepsis, trauma, and neurosurgery patients?
Boldt J; Papsdorf M; Rothe A; Kumle B; Piper S
Crit Care Med; 2000 Feb; 28(2):445-50. PubMed ID: 10708181
[TBL] [Abstract][Full Text] [Related]
10. New criteria for sepsis-induced coagulopathy (SIC) following the revised sepsis definition: a retrospective analysis of a nationwide survey.
Iba T; Nisio MD; Levy JH; Kitamura N; Thachil J
BMJ Open; 2017 Sep; 7(9):e017046. PubMed ID: 28963294
[TBL] [Abstract][Full Text] [Related]
11. Dynamic evolution of coagulopathy in the first day of severe sepsis: relationship with mortality and organ failure.
Dhainaut JF; Shorr AF; Macias WL; Kollef MJ; Levi M; Reinhart K; Nelson DR
Crit Care Med; 2005 Feb; 33(2):341-8. PubMed ID: 15699837
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of the biomarkers procalcitonin, interleukin-6 and C-reactive protein in severe sepsis.
Miguel-Bayarri V; Casanoves-Laparra EB; Pallás-Beneyto L; Sancho-Chinesta S; Martín-Osorio LF; Tormo-Calandín C; Bautista-Rentero D
Med Intensiva; 2012 Nov; 36(8):556-62. PubMed ID: 22495097
[TBL] [Abstract][Full Text] [Related]
13. Dysregulation of inflammatory and hemostatic markers in sepsis and suspected disseminated intravascular coagulation.
Hoppensteadt D; Tsuruta K; Hirman J; Kaul I; Osawa Y; Fareed J
Clin Appl Thromb Hemost; 2015 Mar; 21(2):120-7. PubMed ID: 24254894
[TBL] [Abstract][Full Text] [Related]
14. Tissue factor pathway inhibitor and P-selectin as markers of sepsis-induced non-overt disseminated intravascular coagulopathy.
Mosad E; Elsayh KI; Eltayeb AA
Clin Appl Thromb Hemost; 2011 Feb; 17(1):80-7. PubMed ID: 19689998
[TBL] [Abstract][Full Text] [Related]
15. Study of usefulness of low-dose IgG for patients with septic disseminated intravascular coagulation.
Takahashi G; Shibata S
Biomark Med; 2020 Sep; 14(13):1189-1196. PubMed ID: 32902321
[No Abstract] [Full Text] [Related]
16. Prognostic value of sepsis-induced coagulation abnormalities: an early assessment in the emergency department.
Innocenti F; Gori AM; Giusti B; Tozzi C; Donnini C; Meo F; Giacomelli I; Ralli ML; Sereni A; Sticchi E; Zari M; Caldi F; Tassinari I; Zanobetti M; Marcucci R; Pini R
Intern Emerg Med; 2019 Apr; 14(3):459-466. PubMed ID: 30535649
[TBL] [Abstract][Full Text] [Related]
17. Clinical experience with polyclonal IgM-enriched immunoglobulins in a group of patients affected by sepsis after cardiac surgery.
Buda S; Riefolo A; Biscione R; Goretti E; Cattabriga I; Grillone G; Bacchi-Reggiani L; Pacini D
J Cardiothorac Vasc Anesth; 2005 Aug; 19(4):440-5. PubMed ID: 16085247
[TBL] [Abstract][Full Text] [Related]
18. [Evaluation of coagulation disorders with thrombelastography in patients with sepsis].
Zhong S; Zhang C; Hu J; Tang Z
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2016 Feb; 28(2):153-8. PubMed ID: 26911948
[TBL] [Abstract][Full Text] [Related]
19. Usefulness of Measuring Changes in SOFA Score for the Prediction of 28-Day Mortality in Patients With Sepsis-Associated Disseminated Intravascular Coagulation.
Iba T; Arakawa M; Mochizuki K; Nishida O; Wada H; Levy JH
Clin Appl Thromb Hemost; 2019; 25():1076029618824044. PubMed ID: 30808223
[TBL] [Abstract][Full Text] [Related]
20. Can recombinant human thrombomodulin increase survival among patients with severe septic-induced disseminated intravascular coagulation: a single-centre, open-label, randomised controlled trial.
Hagiwara A; Tanaka N; Uemura T; Matsuda W; Kimura A
BMJ Open; 2016 Dec; 6(12):e012850. PubMed ID: 28039291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
